Lycium barbarum Reduces Abdominal Fat and Improves Lipid Profile and Antioxidant Status in Patients with Metabolic Syndrome

Figure 3

Hepatic enzyme patients with MS in the control group (C) and supplemented group (S) at the beginning, at day 15, and at day 45 after intervention. Evaluation of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in patients with metabolic syndrome. AST (a) and ALT (b) were evaluated before (group baseline) and 15 (15C and 15S) and 45 days (45S) after supplementation with 14 g of goji berry daily. The control group (closed bars) supplemented with goji (open bars). Values of were considered statistically significant when comparing the baseline time with the end time of intervention in each group, using ANOVA followed by the Bonferroni post hoc test.

(a)

(b)